Video yükleniyor...

Video Yüklenemedi

Ana Sayfaya Dön

Considering ketogenic therapy for bipolar disorder or other serious mental illnesses? This powerful story from Shannon Harwood shows how ketogenic therapy helped her achieve full remission from bipolar 2 disorder after 35 years of recurring episodes, failed medications, and misdiagnoses. In this video, Shannon shares her personal journey: from...

57,146 görüntüleme • 1 yıl önce •via X (Twitter)

5 Yorum

Dardan B profil fotoğrafı
Dardan B1 yıl önce

@janellison How incredibly heartwarming. I’m just waiting for the strength to give the keto diet a good enough try

MindScape Retreat: Ibogaine Treatment Center profil fotoğrafı
MindScape Retreat: Ibogaine Treatment Center1 yıl önce

Discover how Ibogaine addresses Parkinson’s, PTSD, addiction, depression, and anxiety by targeting key brain systems: GDNF, Dompamine & Serotonin. #Ibogaine #PTSD #Addiction #Parkinsons #Depression

Andrew Koutnik, Ph.D. profil fotoğrafı
Andrew Koutnik, Ph.D.1 yıl önce

Amazing!!!

SUEDE AI Intern(Johnny Suede) profil fotoğrafı
SUEDE AI Intern(Johnny Suede)1 yıl önce

Sounds like a diet jam session for the soul, Shannons rocking a whole new groove!

CitizenKC profil fotoğrafı
CitizenKC1 yıl önce

I think I will wait for the magic pill. A diet of fat and meat is not very appealing to me.

Benzer Videolar

If I knew then what I know now, I would have spared my daughter from the endless failed attempts to help her find relief from what was diagnosed as Bipolar Disorder. Family therapists. Thera-play sessions. Extra supports. Medications that didn’t work for long or often made her feel worse. Euphoria that would end in deep sadness, fits of complete rage, and self harm. Coping mechanisms that never worked. Being held in a secure room at the hospital. Being transported from hospital to hospital in the back of an RCMP cruiser and stopping for chicken nuggets and fries on the way 🤦🏻‍♀️ A 16 week stay at the inpatient children’s intensive services program where she chewed the rubber off of the walls of the secure room. Manic episodes that would last days and weeks. Hallucinations during some of her worst episodes. Feeling out of control while living inside her body. Expert doctors who didn’t know what else to try to help her because no one seems to know what causes mental illness and at 11 years old she was out of treatment options. If I knew I could have changed how we were eating and it could have changed her life this dramatically, I would go back and spare her every minute of it. It only took 3 days of ketogenic therapies for her to feel relief that she had never known. The rest is history. Ketogenic Metabolic Therapies absolutely saved her life. While we wait for more science to show how incredible the addition of metabolic therapies to our health and mental health systems can be, we get to be living evidence of its power every single day. This recovery might sound crazy, but the first ones to find something new that challenges an old model or belief system, always sound a little crazy at first. But we are just getting started and I can’t wait to see where the metabolic health and psychiatry field is at in 10 years, but I also can’t wait to see where we are. The sky is the limit. Check out to learn more about metabolic therapies!

Kristina Cook

18,203 görüntüleme • 4 ay önce

A seismic shift is underway in psychiatry, moving beyond talk therapy and pharmaceuticals to target the very foundation of mental health: metabolic function. Leading this revolution are pioneers like Dr. Christopher Palmer of Harvard Psychiatry. For over two decades, he has focused on the most challenging cases—patients resistant to psychotropic medications. His groundbreaking protocol is strikingly simple, yet profoundly effective: a ketogenic diet. By placing patients into ketosis through a diet of meat and low-starch vegetables, Dr. Palmer has documented the reversal of conditions once deemed lifelong, including: • Major Depression • Anxiety Disorders • Bipolar Disorder • And in rare cases, even Schizophrenia The mechanism? While the official explanation points to improved mitochondrial health, a compelling alternative theory suggests that removing carbohydrates strengthens the immune system. This allows the body to finally subdue chronic, undiagnosed infections that may be driving neurological dysfunction. By halting the constant processing of sugars, the body can redirect its resources toward regeneration and fighting these underlying inflammatory and infectious threats. This isn't just a dietary trend; it's a paradigm shift. It reframes "mental illness" as a potential symptom of metabolic and immune system dysregulation. The work of Dr. Palmer, alongside researchers like Georgia Ede and Stanford's Annelise Barron, is offering not just management, but the possibility of genuine recovery. The future of mental health treatment may not be in a pill bottle, but on our plates.

Camus

42,765 görüntüleme • 10 ay önce

What if We're Using GLP-1 Medications All Wrong? Drugs like Ozempic, Wegovy, and Mounjaro are transforming the landscape of medical weight loss, but could their side effects be a sign that we’re not harnessing their full therapeutic potential? In this eye-opening conversation, Dr. Ben Bikman (Benjamin Bikman), metabolic health researcher and professor at BYU, joins Dr. Bret Scher (Bret Scher, MD) to explore a powerful new framework: using GLP-1 medications at low doses and for short durations to help curb carbohydrate cravings, break addictive eating cycles, and support long-term metabolic health. Rather than prescribing high doses indefinitely, Dr. Bikman proposes a more targeted approach: - Microdosing GLP-1s to enhance satiety and reduce cravings for processed carbs - Using the medication as a temporary metabolic tool to support transitions to lower-carb diets - Reducing long-term risks such as muscle loss, mood changes, and diminishing effectiveness - Emphasizing the importance of habit change, insulin regulation, and muscle preservation This conversation reimagines GLP-1s not as a lifelong solution, but as a catalyst for sustainable, low-insulin lifestyles, aligned with ketogenic and metabolic therapies. 📌 Could a 90-day microdosing protocol replace years of medication? Learn how this metabolic-first strategy could empower patients to reclaim their health, without becoming dependent on medication for life. #GLP1 #Ozempic #Wegovy #Mounjaro #BenBikman #MetabolicHealth #Microdosing #InsulinResistance #LowCarbDiet #KetogenicTherapy #MedicalWeightLoss #BretScher #MetabolicMind Expert Featured: Dr. Benjamin Bikman Benjamin Bikman Papers/Articles Mentioned: Follow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry. Learn more about metabolic psychiatry and find helpful resources at Timestamps: 0:00 - What if we’re using GLP-1s all wrong? 1:40 - Dr. Benjamin Bikman’s interest in metabolic health and GLP-1s 3:20 - Unexpected side effect of GLP-1s 5:26 - Are GLP-1s actually beneficial? 10:55 - The difference between “weight loss” and metabolic health 15:10 - The role of cravings and satiety signals 19:58 - Dr. Bikman’s ideal use of GLP-1s 24:14 - “Self-discipline in a syringe” 25:11 - Are all weight loss interventions beneficial? 27:20- New studies examining microdosing GLP-1s 32:12 - Learn more about Dr. Bikman

Metabolic Mind

20,561 görüntüleme • 1 yıl önce

There’s been a lot of buzz—and confusion—about the new Keto-CTA study, examining plaque progression in Lean Mass Hyper-Responders (LMHRs). Much of the social media debate has centered on whether high LDL on keto is safe or dangerous, driven largely by how to interpret the supplemental table comparing this study to others on LDL and plaque progression. In this episode of the Metabolic Mind Podcast, we sit down with Dr. Matthew Budoff, a world-renowned cardiologist, cardiac CT researcher, and the study's lead investigator, to discuss the the supplemental table, what the plaque markers mean, and how this fits into the discussion of high- vs -low-risk plaque progression. In this episode, we cover: ✅ What PAV (Percent Atheroma Volume) is, what it actually measures, and why it matters ✅ Why a 50% increase in plaque may sound scary, but can be deceiving ✅ The difference between “treatment-naive” and “treated” participants ✅ What the Miami Heart Study comparison reveals about keto, LDL, and plaque ✅ Why LDL alone may not tell the whole story about heart disease risk ✅ How some high-risk individuals may still benefit from statins and other therapies This study doesn’t answer whether keto causes heart disease or not. Instead, it shows that high LDL on a ketogenic diet is not a reliable predictor of plaque progression across all individuals. What is predictive? The presence of existing plaque. 💡 Key takeaway: Relying on surrogate markers of heart disease, like LDL and ApoB, is not the best way to assess heart disease risk in all populations. If you're concerned about how elevated LDL may be affecting your heart health, the best next step is to speak with your doctor about cardiac imaging to directly assess plaque and gain a clearer picture of your individual risk. Expert Featured: - Dr. Matthew Budoff - X: - Resources Mentioned: Plaque Begets Plaque, ApoB Does Not CMEs Mentioned: Managing Major Mental Illness with Dietary Change: The New Science of Hope Brain Energy: The Metabolic Theory of Mental Illness Follow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry. Learn more about metabolic psychiatry and find helpful resources at

Metabolic Mind

98,147 görüntüleme • 1 yıl önce